Bengaluru-based biotechnology startup, CrisprBits Private Limited, has inaugurated a CRISPR gene editing and diagnostics ...

(Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary gene editing toolbox, today provided updates on the successful ...

Our writer thinks these two speculative shares offer high long-term growth potential from where they currently sit in the ...

New facility to support advancements in molecular diagnostics, rare disease research, and industrial microbiology ...

CRISPR stock decline is influenced by Editas Medicine's struggles, but CRSP remains strong with FDA approval and strategic ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

When rice is in its flowering and grain-filling stages, it is more sensitive to high nighttime temperatures than high daytime ...

"We’re in very different place," the CEO of Editas says, citing the CRISPR pioneer's plans to get its first treatments into ...

Ghanaian-born engineer, inventor, and telecommunications expert, Dr. Victor B. Lawrence, has received the prestigious ...

Colossal, a leading biosciences company working to combat environmental dangers and revive extinct species, has reached a new ...

Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends lifespan by about 50 percent in a mouse model of the fatal ...